Significant Ownership of Ph.D. John P. McKearn
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Ph.D. John P. McKearn focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- San Diego, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Ph.D. John P. McKearn with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Ph.D. John P. McKearn
Significant Ownership of Ph.D. John P. McKearn
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SPRB | SPRUCE BIOSCIENCES, INC. | Common Stock, par value $0.001 per share | 4.2% | $140,762 | 1,759,521 | John P. McKearn, Ph.D. | 07 Jan 2025 | ||
| RPHM | OnKure Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 1.6% | $333,517 | 196,198 | John P. McKearn, Ph.D. | 16 Jan 2025 |
Schedules 13D/G Reported by Ph.D. John P. McKearn:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.